Navigation Links
Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors

BARCELONA, Spain, June 24 /PRNewswire/ -- Spanish biotechnology company Progenika Biopharma, specializing in the development of personal medicine technology, has granted Grifols exclusive world-wide distribution rights for its BLOODCHIP® molecular biology products.  BLOODCHIP® products are used for genotyping of blood donors to assure the compatibility of blood for transfusion between donor and recipient.

Under this agreement, Grifols takes a further step towards the consolidation of its Diagnostic division, expanding its range of products at the leading edge of immunohematology technology.   In addition, Grifols' presence in more than 90 countries will global distribution of the BLOODCHIP® product line.  Likewise, the international presence of Grifols in more than 90 countries through the 22 Grifols' affiliates assures effective global distribution of the test.  

The new product line is expected to generate revenues of between euro 50 and euro 100 million over the next 5 years. Although the use of molecular biology tests in transfusion compatibility is still at its early stages, its use is expected to become more widespread as a result of the hemovigilance and transfusion safety plans being introduced in many countries.

Victor Grifols, President and CEO of Grifols stated: "This agreement will allow us to strengthen our Diagnostic Division and consolidate our global position in the field of blood grouping with a new innovative tool that increases transfusion safety."  For his part, Antonio Martinez, CEO of Progenika, noted that, "This distribution agreement ensures that our products will be properly marketed, and allows us to focus on the development of new diagnostic and therapeutic tools that improve quality of life."

About the BLOODCHIP® test

BLOODCHIP® is an integrated circuit that determines the main allelic variants of blood groups and platelet antigens by analyzing 128 genetic polymorphisms.  The test is used to prevent potential transfusion reactions in those patients for whom conventional serological tests are insufficient.

The BLOODCHIP® test already holds a CE mark for marketing in Europe and has been developed by the Bloodgen Consortium, a leading European group consisting of blood banks, research institutes and Progenika Biopharma, SA., whose mission is to improve patient safety and transfusion compatibility by blood group and genotype.  

About Grifols

Grifols is a Spanish holding company, specializing in the hospital-pharmaceutical sector, and with a presence in over 90 countries. Since May 2006 it has been listed on the Spanish Continuous Market, and since 2008 it has been included in the Ibex-35. It focuses on the research, development, manufacture and marketing of plasma products, diagnostic systems, intravenous therapies, enteral nutrition and medical supplies. In recent years Grifols has made significant investments in the area of transfusionmedicine to ensure the strategic and technological position of the company in this area.

About Progenika

Progenika, a Spanish company which specializes in personalized medicine., develops DNA biochips for the diagnosis, prognosis and prediction of response to treatment of complex human illnesses. Progenika offers DNA based tests in areas such as: oncology, the lipids, Nervous System diseases or the optimization of its treatments. Among its out-standing products, in addition to the BLOODchip, they find the LIPOchip, PHARMAchip, Promonitor, BRAINchip.  Progenika was founded in 2000. Its development and production centers are located in the Zamudio Technology Park (in Spain) and in Cambridge (Massachusetts, USA), and it has commercial and intellectual property management offices in Madrid and London. Over 140 scientists are currently employed by the company, which products are commercialized in America, Europe and Middle East.

For more information please visit

SOURCE Grifols, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
2. Chinese Biopharmaceutical Association Holds 15th Annual Conference in Rockville, MD, June 12 - 13
3. IntraLinks Announces Partnership With SAFE-BioPharma; Will Provide Digital Identity Capabilities With its Life Sciences Solutions
4. PDL BioPharma to Announce First Quarter 2010 Financial Results and Hold Conference Call on April 29, 2010
5. PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance
6. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
7. Indiana Biopharmaceutical Service Providers Maintain Steady Growth Despite Industry Challenges
8. SynCo Bio Partners Signs New Manufacturing Agreements to Supply the US Market; Securing its Position as a Market Leader in Microbial Biopharmaceutical Contract Production
9. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
10. Sinobiopharma Announces Second Quarter 2010 Financial Results
11. Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry
Post Your Comments:
(Date:10/8/2015)... Maryland , October 8, 2015 ... .   --> Goldman Small ... in the small cap and microcap sectors, announced ... research report on PharmaCyte Biotech, Inc. (OTCQB - ... focused on developing and preparing treatments for cancer ...
(Date:10/8/2015)... , Oct. 8, 2015  Today, DuPont and ... for genome editing, jointly announced a strategic alliance. ... cross-licensed their respective patent portfolios, with DuPont receiving ... in major row crops, and non-exclusive rights in ... --> --> In ...
(Date:10/8/2015)... the Wyss Institute for Biologically Inspired Engineering at Harvard ... Opsonix Inc. The announcement follows a worldwide exclusive ... (OTD) and Opsonix Inc. enabling the company to ... --> --> Pathogen-induced ... in the U.S. — more than prostate cancer, breast ...
(Date:10/8/2015)... ... October 08, 2015 , ... ProMIS Neurosciences, Inc. (TSX: PMN), ... and commercialize intellectual property rights belonging to The University of British Columbia (UBC). ... exclusive worldwide rights to intellectual property based on use of the ProMIS™ technology, ...
Breaking Biology Technology:
... the biggest challenge in the world, and we have to ... inefficiencies can be attributed to transportation (27 percent), industry (25 ... the U.S. Energy Information Administration statistics published in ... of Fermi Labs . He also said the only ...
... As the completion of an audit into state information technology ... IT project. , ,According to a report in the ... Development has decided to stop work on a new ... system, known as Enhanced Automated Benefits Legal Enterprise Services, or ...
... Wis. - Gregg Fergus can tell his fellow travelers ... has joined Baird Venture Partners as an executive-in-residence ... as senior vice president of corporate development. , , ... Silicon Valley California for the past nine years, his new ...
Cached Biology Technology:
(Date:10/8/2015)... , 8. Oktober 2015 ... global tätiges Unternehmen des Bereiches Tracking, hat ... mit der Gefängnisbehörde Virginias (Department of Corrections ... elektronische Überwachungsdienste für alle Strafen geliefert werden, ... Cassell , Präsident für den Amerikanischen Kontinent ...
(Date:10/6/2015)... , Oct. 6, 2015  Maverix Biomics, Inc., ... enhancements to its software portfolio with the debut ... for differential expression in eukaryotes. The software is ... a cloud-based genomic analysis solution that leverages proven ... from next-generation sequencing efforts. Garry Nolan,s ...
(Date:9/30/2015)... , Sept. 30, 2015  The U.S. Court ... issued another key ruling in favor of Crossmatch ... Korean fingerprint scanner company Suprema and its U.S. partner ... 1930, a trade provision that declares it unlawful to ... by infringing two of Crossmatch,s patents, the 5,900,993 patent ...
Breaking Biology News(10 mins):
... Kemira Oyj and VTT Technical Research Centre of Finland ... The present Finnish competence of the water sector is being ... new and unique competence of the water sector in Finland ... environmental technology sector. The research centre will be known ...
... Kansas State University study found that the availability of ... the risk of obesity for low-income women living in ... eating behaviors might need to be tailored based on ... food stores for low-income women in Kansas to see ...
... in an autumn breeze may evoke a peaceful scene. ... that took place in the spring. In particular, young ... of insects that lay eggs in their apical-leaf buds, ... completely prevent goldenrod from flowering and producing seeds. ...
Cached Biology News:
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Mfr Desig: ...
Mouse monoclonal antibody to QARS - glutaminyl-tRNA synthetase...
From formula-fed bovine calves Sterile, Cell culture tested...
... numbers of samples may be carried out using ... minimum operator attention. System control and data ... CE 4900. The elegant, powerful and very ... and Windows 98 and 2000., The supplied automatic ...
Biology Products: